Physician profile
Aron Simkins
NPI 1093197931
$63,046.13
in general payments reported to CMS, 2019-2025
84 companies · $19K in 2025
The $19K reported for 2025 was more than what 92% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $138 · 2021: $776 · 2022: $3,857 · 2023: $6,354 · 2024: $33K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $34K · Food and Beverage: $18K · Travel and Lodging: $3,274 · Consulting Fee: $2,810 · Education: $68.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $33,600.00 |
| Food and Beverage | $18,201.64 |
| Travel and Lodging | $3,274.26 |
| Consulting Fee | $2,810.00 |
| Education | $68.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $41,010.77 | 2021-2025 | |
| Janssen Biotech, INC. | $1,575.93 | 2022-2025 | Erleada, Darzalex, Rybrevant |
| Celgene Corporation | $1,468.84 | 2020-2025 | Reblozyl, Onureg, Abecma |
| Astrazeneca Pharmaceuticals LP | $1,380.49 | 2021-2025 | Imfinzi, Lynparza, Datroway |
| Merck Sharp & Dohme LLC | $1,226.15 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $1,150.95 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,122.56 | 2022-2025 | |
| Daiichi Sankyo INC. | $1,019.24 | 2021-2025 | Enhertu, Injectafer, Datroway |
| Astellas Pharma US INC | $744.51 | 2019-2025 | Xospata, Xtandi, Padcev |
| Genentech USA, INC. | $644.64 | 2019-2025 | Tecentriq, Venclexta, Tecentriq Hybreza |
| Abbvie INC. | $570.50 | 2022-2025 | Venclexta, Linzess, Viberzi |
| Incyte Corporation | $506.20 | 2020-2025 | Jakafi, Pemazyre, Monjuvi |
| Genzyme Corporation | $465.30 | 2021-2025 | |
| Glaxosmithkline, LLC. | $458.93 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Beigene USA, INC. | $449.26 | 2021-2025 | Brukinsa, Tevimbra |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $423.84 | 2023-2025 | Orgovyx |
| Array Biopharma INC | $420.32 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| Takeda Pharmaceuticals U.S.A., INC. | $415.67 | 2022-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Tempus Ai, INC | $405.90 | 2024-2025 | Xt Cdx |
| Bayer Healthcare Pharmaceuticals INC. | $380.89 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $337.20 | 2022-2025 | Myrisk, Prolaris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.32 | 2023-2025 | Gilotrif |
| E.R. Squibb & Sons, L.L.C. | $303.77 | 2022-2025 | Opdivo, Opdualag, Krazati |
| Amgen INC. | $293.74 | 2020-2023 | Lumakras, Kyprolis |
| Taiho Oncology, INC. | $285.63 | 2023-2025 | |
| Lilly USA, LLC | $266.95 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Exelixis INC. | $265.89 | 2019-2025 | Cabometyx |
| Emd Serono, INC. | $256.10 | 2022-2025 | Bavencio |
| Regeneron Healthcare Solutions, INC. | $252.27 | 2023-2025 | Libtayo |
| Deciphera Pharmaceuticals INC. | $234.35 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Ipsen Biopharmaceuticals, INC | $227.83 | 2023-2025 | Onivyde, Somatuline Depot, Tazverik |
| Beone Medicines USA, INC. | $224.80 | 2025 | Brukinsa, Tevimbra |
| Seagen INC. | $223.46 | 2022-2023 | Padcev, Tukysa, Adcetris |
| Jazz Pharmaceuticals INC. | $210.99 | 2022-2025 | |
| Adaptive Biotechnologies Corporation | $205.90 | 2022-2025 | Clonoseq |
| Sobi, INC | $202.65 | 2023-2025 | |
| Springworks Therapeutics, INC. | $194.51 | 2024-2025 | Ogsiveo, Gomekli |
| Sirtex Medical INC | $190.90 | 2022 | |
| Genmab U.S., INC. | $181.30 | 2023-2025 | Epkinly |
| Rigel Pharmaceuticals, INC. | $173.20 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Mirati Therapeutics, INC. | $169.04 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $138.84 | 2023-2025 | |
| Stemline Therapeutics INC. | $138.68 | 2023-2025 | Orserdu |
| Pharmacosmos Therapeutics INC. | $109.54 | 2023-2025 | Monoferric, Cosela |
| Intuitive Surgical, INC. | $93.69 | 2025 | |
| Adc Therapeutics America, INC. | $93.54 | 2022 | |
| Geron Corporation | $92.92 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $87.47 | 2024-2025 | Ayvakit |
| Sanofi US Services INC. | $83.20 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $79.69 | 2022-2023 | Epkinly, Imbruvica |
| Aveo Pharmaceuticals, INC. | $79.48 | 2022-2025 | Fotivda |
| Tersera Therapeutics LLC | $75.98 | 2024-2025 | Zoladex |
| Foundation Medicine, INC. | $75.98 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $75.02 | 2024-2025 | Provenge |
| Morphosys, US INC. | $70.51 | 2022-2023 | Monjuvi |
| Epizyme, INC. | $69.05 | 2022-2023 | Tazverik |
| Caris Mpi, INC. | $65.63 | 2025 | Mi Cancer Seek |
| Cti Biopharma Corp. | $57.54 | 2022-2023 | Vonjo |
| Puma Biotechnology, INC. | $56.83 | 2022-2025 | |
| Kyowa Kirin, INC. | $44.80 | 2022 | |
| Agios Pharmaceuticals, INC. | $44.34 | 2024-2025 | Pyrukynd |
| Abbott Laboratories | $43.26 | 2022-2024 | Freestyle Libre |
| Janssen Pharmaceuticals, INC | $41.21 | 2022-2025 | Xarelto |
| Gilead Sciences, INC. | $38.08 | 2022 | |
| Tolmar, INC. | $35.57 | 2023-2025 | Rubraca |
| Alexion Pharmaceuticals, INC. | $31.79 | 2024 | Ultomiris |
| Sun Pharmaceutical Industries INC. | $30.68 | 2025 | |
| Iovance Biotherapeutics, INC. | $25.17 | 2025 | Amtagvi |
| Immunogen, INC. | $24.78 | 2023 | Elahere |
| Myovant Sciences INC. | $23.78 | 2022 | |
| Pharmaand Gmbh | $21.07 | 2025 | Rubraca |
| Invivyd INC | $21.05 | 2025 | Pemgarda |
| Recordati_rare_diseases_inc. | $20.55 | 2024 | Sylvant |
| G1 Therapeutics, INC. | $20.41 | 2023 | Cosela |
| Blue Earth Diagnostics | $19.50 | 2022 | |
| Nuvation Bio INC. | $19.04 | 2025 | Ibtrozi |
| Clovis Oncology, INC. | $18.81 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.66 | 2022 | |
| Menarini Silicon Biosystems, INC. | $16.08 | 2025 | Cellsearch |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.40 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.17 | 2025 | Danziten |
| Coloplast Corp | $14.57 | 2023 | Speedicath |
| Fennec Pharmaceuticals, INC. | $14.25 | 2024 | Pedmark |
| Angiodynamics, INC. | $13.83 | 2023 | Nanoknife |
Drugs and devices associated with these payments
Lenvima $41KReblozyl $1,040Keytruda $924Orgovyx $719Erleada $691Xtandi $511Kisqali $509Enhertu $503Braftovi $479Brukinsa $418Xt Cdx $406Lynparza $397Mektovi $377Imfinzi $365Pluvicto $338Padcev $333Sarclisa $290Lonsurf $286Inqovi $286Xospata $259Talzenna $255Libtayo $252Tukysa $252Darzalex $247Datroway $241Nubeqa $238Gilotrif $233Ojjaara $230Venclexta $229Xofigo $226Lorbrena $225Ayvakit $224Bosulif $215Onivyde $211Elrexfio $209Epkinly $201Adcetris $201Elahere $200Rybrevant $193Krazati $189Opdivo $188Ogsiveo $176Tevimbra $176Tecvayli $164Doptelet $161Cabometyx $153Qinlock $152Ninlaro $152Monjuvi $146Injectafer $143Clonoseq $141Orserdu $139Jakafi $136Akeega $126Zepzelca $117Xalkori $117Bavencio $117Tibsovo $114Verzenio $113Lutathera $113Myrisk $112Piqray $111Tecentriq $109Calquence $101Pemazyre $97.82Welireg $95.99Jaypirca $95.47Vyndaqel $95.00Da Vinci Surgical System $93.69Rytelo $92.92Alunbrig $92.07Stivarga $90.51Fruzaqla $86.68Inlyta $86.26Ibrance $84.04Linzess $80.69Jemperli $79.57Zejula $79.17Carvykti $77.07Imbruvica $76.49Vonjo $76.13Zoladex $75.98Talvey $75.23Provenge $75.02Tavalisse $74.21Rezlidhia $74.21Cosela $73.26Iclusig $73.24Retevmo $73.15Prolaris $67.00Mi Cancer Seek $65.63Blenrep $65.50Fabhalta $64.82Fotivda $64.54Tazverik $62.29Tecentriq Hybreza $61.42Monoferric $56.69Viberzi $53.78Opdualag $51.24Idhifa $48.51
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aron Simkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.